Nicholas DeVito, Assistant Professor of Medicine at the Division of Medical Oncology at Duke University, shared a post on LinkedIn:
“I didn’t think I would ever be thrilled to see another EPIC notification, but Erica Gray, PharmD, BCPS found an exception! PPIs, steroids, and acetaminophen all trigger drug-drug interactions in Lexidrug when prescribing immunotherapy. Along with patient/provider education, this is key to improving outcomes with immune checkpoint inhibitors in oncology.
These are the steps we were hoping to see when we wrote our JCO article earlier this year (ICYMI).”
Title: Addressing Common Medications That Influence Immunotherapy Response in Solid Tumors
Authors: Nicholas DeVito, Erica Gray, Daniel Schrum, Scott Antonia
Read The Full Article
Other articles about immunotherapy on OncoDaily.